Skip to main content
Premium Trial:

Request an Annual Quote

Scripps to use RainDance Technology in 'Wellderly' Study

NEW YORK (GenomeWeb News) – The Scripps Translational Science Institute will use RainDance Technologies’ sequence enrichment application as part of its ongoing research into the genetics of healthy elderly Americans.
Scripps’ “Wellderly” Study is collecting DNA from volunteers for a gene bank. The samples will be studied by Scripps researchers to identify protective elements of the human genetic code.
Lexington, Mass.-based RainDance said that its technology will be used in a proof-of-principle study to show the effectiveness of its RainStorm technology in amplifying a large number of genomic loci across a diverse set of samples. The firms said that the technology will enable researchers to perform millions of individual PCR reactions per day using conventional thermocyclers.

“We believe our collaboration will accelerate the completion of the program’s research objectives by using RainDance’s sequence enrichment application to enhance the efficiency of STSI’s next-generation sequencing technology,” RaindDance President and CEO Chris McNary said in a statement.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.